Harvard Atherosclerosis Reversibility Project (HARP)

NCT00000461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia

Interventions

DRUG: pravastatin
DRUG: niacin
DRUG: cholestyramine
DRUG: gemfibrozil
DRUG: fatty acids, omega-3

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)